Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
暫譯: 針對淋巴瘤的靶向療法抗藥性（不包括抗體）

Ferreri, Andres J. M.

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
  • 出版商: Springer
  • 出版日期: 2019-01-26
  • 售價: $4,820
  • 貴賓價: 9.5 折 $4,579
  • 語言: 英文
  • 頁數: 154
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 3030091651
  • ISBN-13: 9783030091651

    • 海外代購書籍(需單獨結帳)

相關主題

商品描述

In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they will result in a better selection of patients with sensitive disease and the establishment of suitable combinations of drugs that target different molecules and could overcome the established resistance.

商品描述(中文翻譯)

在過去十年中，關於不同淋巴瘤類別的分子機制和活化途徑的文獻呈指數增長，隨之而來的是針對性療法的更廣泛和成功的應用。在本書中，專家作者重新探討了這些療法中最相關的方面，特別強調了分子機制和抗藥性的臨床效果。了解腫瘤對靶向療法的抗藥性所涉及的基本機制至關重要，因為這將有助於更好地選擇對治療敏感的患者，並建立針對不同分子的合適藥物組合，以克服已建立的抗藥性。

作者簡介

Andrés J. M. Ferreri has a degree in Medicine from the Facultad de Medicina of the Universidad de Buenos Aires, Argentina (1985), and obtained the degree of Doctor in Medicine and Surgery in the Facoltà di Medicina e Chirurgia dell'Università degli Studi di Parma, Italy, in 1992. He is a Specialist in Clinical Oncology (Università degli Studi di Milan, Italy, 2005). He was a research fellow at the Divisione di Oncologia Sperimentale "E" and at the Divisione di Oncologia Médica "A" of the Istituto Nazionale dei Tumori of Milan (1989-1994) and vice-director of the Medical Oncology Unit of the San Raffaele Scientific Institute of Milan, Italy. Currently, Dr. Ferreri is Head of the Unit of Lymphoid Malignancies of the San Raffaele Scientific Institute of Milan, and is a Contract Professor of Oncology in the Vita e Salute University, Milan. He is fully devoted to the research on non-Hodgkin lymphomas and is an opinion leader in the field of extranodal lymphomas. Dr. Ferreri is Associate Editor of the ESO/START Project and of "Haematological Oncology" and Faculty of the European School of Oncology. Dr. Ferreri is a member of EHA, ESMO, ASH, and ASCO.

作者簡介(中文翻譯)

安德烈斯·J·M·費雷里（Andrés J. M. Ferreri）於1985年獲得阿根廷布宜諾斯艾利斯大學醫學院的醫學學位，並於1992年在意大利帕爾馬大學醫學與外科學院獲得醫學與外科博士學位。他是臨床腫瘤學專家（2005年，意大利米蘭大學）。他曾在米蘭國家腫瘤研究所的實驗腫瘤學「E」部門和醫學腫瘤學「A」部門擔任研究員（1989-1994），並擔任米蘭聖拉斐爾科學研究所醫學腫瘤學單位的副主任。目前，費雷里博士是米蘭聖拉斐爾科學研究所淋巴惡性腫瘤單位的負責人，並在米蘭的維塔與健康大學擔任腫瘤學的合約教授。他全心投入於非霍奇金淋巴瘤的研究，並在外周淋巴瘤領域中是意見領袖。費雷里博士是ESO/START計畫和《血液腫瘤學》的副編輯，並且是歐洲腫瘤學院的教員。費雷里博士是歐洲血液學會（EHA）、歐洲腫瘤學會（ESMO）、美國血液學會（ASH）和美國臨床腫瘤學會（ASCO）的成員。

類似商品